News – Page 1094 – Endpoints News

SIGN UP

In a rare misfire, Regeneron scraps its RSV drug after a PhIII failure

8 years ago

Merck CEO Ken Frazier resigns from Trump council in protest, and the president swiftly bites back

8 years ago

Zynerba shares crushed (again) as back-to-back flops leave lead drug under a cloud

8 years ago

Focused on data and drug development, SoftBank hunts new $1B biotech deals — report

8 years ago

Mundipharma picks up a PhIII-ready chemo creation in $250M deal

8 years ago

Novartis partner Ophthotech says wet-AMD drug Fovista goes 0-for-3 in PhIII

8 years ago

Novartis veteran David Epstein takes leadership role at Rubius

8 years ago

Here's why Sucampo paid $200M for its PhIII Niemann-Pick drug

8 years ago

Peregrine slashes R&D in a reorg that claims 60 jobs; Zai Labs in hunt for $150M IPO - report

8 years ago

GSK abandons Ionis' FDA-ready inotersen as new CEO sweeps out rare disease efforts

8 years ago

Dicerna escalates war with Alnylam over RNAi secrets, claiming its rival wants a monopoly

8 years ago

Gilead circles February 12 on its calendar as D-day for its HIV franchise

8 years ago

Gushing red ink, biotech billionaire Soon-Shiong slashes staff at NantHealth by 300, sells assets

8 years ago

Takeda strikes a combo I/O discovery pact with Shattuck Labs; Facing FDA rejection, Egalet slashes staff

8 years ago

Apellis grabs $60M to pay for a looming PhIII showdown with Alexion's Soliris

8 years ago

UK’s Biotecnol strikes a deal with CRUK to move new immuno-oncology drug into PhI

8 years ago

Zealand bags a $77M IPO haul as investors embrace another biotech offering

8 years ago

Eyeing an IPO, Sutro retools its $1B I/O deal with Celgene but stays focused on BCMA

8 years ago

Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?

8 years ago

Galapagos spotlights an 'exciting' round of PoC data for IPF drug, shares surge

8 years ago

Citing a ‘conflict,’ GSK vet Slaoui abruptly quits Intellia board

8 years ago

Ardelyx brings out the ax, chopping 28% of staffers; PRA bags Symphony Health Solutions in $530M acquisition

8 years ago

Orbimed partner in search of a cure for Parkinson’s launches new gene therapy player

8 years ago

Spurred by Gottlieb, FDA on track to the most generic drug OKs ever in 1 year

8 years ago

First page Previous page 1091 1092 109310941095 1096 1097 Next page Last page